By integrating digital tools like ePRO, we can bridge the gap between patients’ lived experiences and clinical research.
The FDA-approved Inluriyo, an oral estrogen receptor antagonist from Eli Lilly, has shown to achieve significant improvement ...
Phoenix PCN Luton is proud to announce that it has been named a winner at the HSJ Patient Safety Awards 2025, recognising ...
Medication safety remains one of the greatest challenges in healthcare worldwide. Despite advances in clinical practice, digital health, and ...
Diligent Robotics co-founder Vivian Chu said her "minimum viable humanoid" robots are already helping hospital staff save ...
Due to a complex set of factors, long-term care facilities routinely refuse to let patients return after they are admitted to ...
ERA met its co-primary endpoints; giredestrant plus everolimus demonstrated significant benefit in ITT and ESR1-mutated populations in post-CDK inhibitor setting, compared with standard of care plus ...
For decades in life sciences, pharmacovigilance (PV)—a critical reinforcer of drug safety—has been a reactive function. Its ...
Third patient in the first cohort is now advancing through protocol-defined evaluations as Company anticipates additional results from second dosing of second patient in the cohort ...
TWO outstanding nurses have been recognised for their leadership and dedication to patient care. Helen Titu, the first cardiology nurse consultant at Wrightington, Wigan and Leigh Teaching Hospitals ...
A separate fear system, flexibly gated by outcome uncertainty, guides decision-making to be both safe and efficient during exploration.
Experts say that pregnant people should not be afraid to take Tylenol, rebuking unproven claims made by the Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback